SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is seeing significant investor attention driven by fresh institutional accumulation, including a notable position from BlackRock, and positive analyst coverage with an Outperform rating. The community is focused on the company's strong alignment with U.S. government quantum research initiatives, upcoming earnings, and the broader long-term potential for its neutral-atom technology to lead the emerging quantum sensing and computing sector.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp. is trending as investors capitalize on the company's status as a sole domestic provider of defense-critical antimony, buoyed by major government contracts and institutional accumulation from firms like BlackRock and State Street. The community is actively debating the stock's short-term volatility amid heavy short interest and sector-wide manipulation, while bulls remain focused on the company's central role in strengthening U.S. domestic supply chains for military and AI infrastructure.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera is gaining significant market attention following a high-value partnership with Jazz Pharmaceuticals and a bullish analyst upgrade, driving optimism around the company's T-cell engager platform and upcoming clinical readouts. Investors are closely monitoring the Phase 2 trial of ABCL635 as a key catalyst, with the community actively debating whether current institutional accumulation signals the start of a sustained rally or a temporary squeeze.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors digest news of its consortium being shortlisted as a finalist for the Mrima Hill rare earth project in Kenya, a move highlighting the company's strategic alignment with Western supply chain security. Despite this development, the stock remains under pressure as market participants weigh the potential of the Kenya project and the Tanbreez deposit against ongoing concerns regarding share dilution and management's communication on project milestones.

Cipher Digital, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business. The company was founded in 2021 and is headquartered in New York, NY.

Cipher Digital Inc.

Cipher Digital is facing significant volatility ahead of its upcoming earnings report, with investors focused on its transition from Bitcoin mining to AI data center infrastructure. The community is actively debating the company's ability to execute on its massive power capacity pipeline and early delivery milestones, weighing recent revenue misses against the long-term potential of its hyperscaler contracts.

Sharplink, Inc. is an institutional-grade Ethereum treasury platform that provides public market investors with exposure to ETH. The platform focuses on Ethereum, which is used in various stablecoin, tokenized real-world asset, and decentralized finance settlement applications. This allows for native yield generation and potential network growth opportunities with ETH. The company is also involved in the online affiliate marketing business. The company was founded in 2019 and is headquartered in Miami, FL.

Sharplink Inc.

SharpLink Gaming Ltd

SharpLink Gaming is drawing attention due to its substantial Ethereum treasury and recent strategic moves to optimize institutional yield, even as the stock faces continued volatility and heavy short interest. Community sentiment is deeply polarized, with many investors closely watching the potential passage of stablecoin and crypto clarity legislation as a critical catalyst for price recovery.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is trending amid community frustration over stalled progress on the Clarity Act, which many investors view as a critical catalyst for institutional adoption. While some participants express deep skepticism and report shifting capital into Bitcoin or equities, others remain patient, arguing that the token's long-term utility in global financial settlement outweighs current price volatility and political gridlock.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is attracting significant community attention following its latest quarterly earnings report, which highlighted strong revenue growth and continued commercial adoption of its flagship therapy, ANKTIVA. Investors are closely monitoring active institutional accumulation and recent regulatory updates while debating the company's long-term potential against persistent short-selling pressure.

Tidal Trust II - YieldMax MSTR Option Income Strategy ETF

YieldMax MSTR Option Income Strategy ETF

MSTY continues to draw significant attention from investors debating the merits of its high-yield option income strategy against ongoing NAV erosion. While some in the community advocate for a long-term hold and reinvestment approach to compound returns, others criticize the fund's price performance and structural risks, leading to heated discussions about whether it serves as a viable income engine or a dividend trap.

Butterfly Network, Inc. designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment. It develops and provides a whole-body portable ultrasound scanner called the iQ Device and related hosted, web-based application, application programming interfaces and platform services, which the firm offer to physicians or other licensed health care providers. Its products include iQ+ Ultrasound, Butterfly Enterprise and iQ Vet. The company was founded by Jonathan M. Rothberg on January 25, 2011 and is headquartered in Burlington, MA.

Butterfly Network Inc - Ordinary Shares - Class A

Butterfly Network Inc

Butterfly Network is surging following news of a partnership with Midjourney to power a new AI-driven full-body scanner, fueling investor excitement around potential multi-stream revenue growth and semiconductor technology licensing. While long-term shareholders are highlighting the stock's significant pipeline and potential for a short squeeze, many community members are debating whether the current price action is a sustainable breakout or a temporary hype-driven spike prone to a correction or share offering.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Record Profits, a Vape Market Landgrab, and a CA$250M Facility Bought for CA$27M 
https://ow.ly/twTw50YpLcg 
 
Atrium Research initiated coverage on Cannara Biotech Inc. ($LOVE.TO; $LOVFF:OTCQX; BCB0:FSE), citing the company&#39;s dominant position in Quebec&#39;s new vape category, best-in-class EBITDA margins of 29%, and a capital-efficient expansion path at its Valleyfield facility that could unlock 100,000 kg of annual production capacity by FY30.

Atrium Research initiated coverage on Cannara Biotech Inc. (LOVE:TSX; LOVFF:OTCQX; BCB0:FSE), citing the company's dominant position in Quebec's new vape category, best-in-class EBITDA margins of 29%, and a capital-efficient expansion path at its Valleyfield facility that could unlock 100,000 kg of annual production capacity by FY30.

Record Profits Vape Market Landgrab & CA$250M Facility Bought for CA$27M

StockTwits Web

Cannara Biotech Inc

Record Profits, a Vape Market Landgrab, and a CA$250M Facility Bought for CA$27M 


 
 
Atrium Research initiated coverage on Cannara Biotech Inc. ($LOVE.TO; 

:OTCQX; BCB0:FSE), citing the company's dominant position in Quebec's new vape category, best-in-class EBITDA margins of 29%, and a capital-efficient expansion path at its Valleyfield facility that could unlock 100,000 kg of annual production capacity by FY30.